ALFA Filings
Every announcement, straight from the exchange
Every Asston Pharmaceuticals annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
9 announcements
Asston Pharmaceuticals Limited concluded its 7th Annual General Meeting on September 29, 2026. Shareholders considered resolutions including adoption of financial statements and director remuneration increases.
Asston Pharmaceuticals Limited announced its Annual General Meeting scheduled for September 29, 2026. The agenda includes adopting financial statements, appointing auditors, and revising remuneration for key managerial personnel.
Asston Pharmaceuticals held an EGM on July 31, 2026. Shareholders approved a special resolution to issue equity shares on a preferential basis.
Asston Pharmaceuticals convened an EGM for July 31, 2026. Shareholders will vote on a special resolution to issue equity shares on a preferential basis.
Asston Pharmaceuticals convened an EGM for July 31, 2026. The agenda includes a Rs. 27.72 Crore preferential allotment of 24.10 lakh equity shares.
Asston Pharmaceuticals Limited conducted an Extraordinary General Meeting on April 28, 2026, via video conferencing. Shareholders considered resolutions including the appointment of M/s Panchal SK & Associates as statutory auditors and the regularization of three directors. The meeting concluded successfully with e-voting facilities provided to members.
Asston Pharmaceuticals Limited announced the voting results of its Extraordinary General Meeting held on April 28, 2026. Shareholders approved the appointment of M/s Panchal SK & Associates as statutory auditors and the regularization of three directors. All resolutions were passed with 100% of the votes cast in favour.
Asston Pharmaceuticals Limited will hold an Extraordinary General Meeting on April 28, 2026, via video conferencing. The company has fixed April 17, 2026, as the record date for determining e-voting eligibility. E-voting will be available from April 23 to April 27, 2026, through NSDL.
Asston Pharmaceuticals Limited has convened an Extraordinary General Meeting on April 28, 2026, via video conferencing. Key agenda items include appointing M/s Panchal SK & Associates as statutory auditors and regularizing the appointments of Mr. Yogesh Supekar, Mr. Yashvardhan Tupe, and Mr. Sandip Sharma to the Board.